![Parag V. Meswani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Parag V.
Meswani formerly worked at Biogen, Inc., as Chief Executive Officer-Commercial Operations, ACADIA Pharmaceuticals, Inc., as Senior Vice President-Trofinetide from 2022 to 2025, Spark Therapeutics, Inc., as Head-US Marketing, and Sio Gene Therapies, Inc., as Chief Commercial Officer from 2020 to 2022.
Dr. Meswani received his undergraduate degree and doctorate degree from Ernest Mario School of Pharmacy and Masters Business Admin degree from Columbia Business School.
Former positions of Parag V. Meswani
| Companies | Position | End |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2025-03-31 |
| SIO GENE THERAPIES INC. | Chief Operating Officer | 2020-10-05 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| SPARK THERAPEUTICS, INC. | Sales & Marketing | - |
Training of Parag V. Meswani
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Parag V. Meswani
Choose MarketScreener 
